Familial hypertrophic cardiomyopathy 1

Common Name(s)

Familial hypertrophic cardiomyopathy 1

Hereditary ventricular hypertrophy (CMH, HCM, ASH, or IHSS) in early stages produces a presystolic gallop due to an atrial heart sound, and EKG changes of ventricular hypertrophy. Progressive ventricular outflow obstruction may cause palpitation associated with arrhythmia, congestive heart failure, and sudden death. {71:Seidman (2000)} reviewed studies of hypertrophic cardiomyopathy in man and mouse. Genetic Heterogeneity of Hypertrophic Cardiomyopathy Additional forms of hypertrophic cardiomyopathy include CMH2 ({115195}), caused by mutation in the TNNT2 gene ({191045}) on chromosome 1q32; CMH3 ({115196}), caused by mutation in the TPM1 gene ({191010}) on chromosome 15q22.1; CMH4 ({115197}), caused by mutation in the MYBPC3 gene ({600958}) on chromosome 11p11.2; CMH6 ({600858}), caused by mutation in the PRKAG2 gene ({602743}) on chromosome 7q36; CMH7 ({613690}), caused by mutation in the TNNI3 gene ({191044}) on chromosome 19q13.4; CMH8 ({608751}), caused by mutation in the MYL3 gene ({160790}) on chromosome 3p21.3-p21.2; CMH9 (see {188840}),is caused by mutation in the TTN gene ({188840}) on chromosome 2q31; CMH10 (see {160781}), caused by mutation in the MYL2 gene ({160781}) on chromosome 12q23-q24; CMH11 ({612098}), caused by mutation in the ACTC1 gene ({102540}) on chromosome 15q14; CMH12 ({612124}), caused by mutation in the CSRP3 gene ({600824}) on chromosome 11p15.1; CMH13 ({613243}), caused by mutation in the TNNC1 gene ({191040}) on chromosome 3p21.3-p14.3; CMH14 ({613251}), caused by mutation in the MYH6 gene ({160710}) on chromosome 14q12; CMH15 ({613255}), caused by mutation in the VCL gene ({193065}) on chromosome 10q22.1-q23; CMH16 ({613838}), caused by mutation in the MYOZ2 gene ({605602}) on chromosome 4q26-q27; CMH17 ({613873}), caused by mutation in the JPH2 gene ({605267}) on chromosome 20q12; CMH18 ({613874}), caused by mutation in the PLN gene ({172405}) on chromosome 6q22.1; CMH19 ({613875}), caused by mutation in the CALR3 gene ({611414}) on chromosome 19p13.11; CMH20 ({613876}), caused by mutation in the NEXN gene ({613121}) on chromosome 1p31.1; CMH21, mapped to chromosome 7p12.1-q21; and CMH22 (see {615248}), caused by mutation in the MYPN gene ({608517}) on chromosome 10q21. The CMH5 designation was initially assigned to a CMH family showing genetic heterogeneity. Subsequently, affected individuals were found to carry mutations in the MYH7 (CMH1) and/or MYBPC3 (CMH4) genes. Hypertrophic cardiomyopathy has also been associated with mutation in the gene encoding cardiac myosin light-peptide kinase (MYLK2; see {606566.0001}), which resides on chromosome 20q13.3; the gene encoding caveolin-3 (CAV3; see {601253.0013}), which maps to chromosome 3p25; and with mutations in genes encoding mitochondrial tRNAs: see mitochondrial tRNA-glycine (MTTG; {590035}) and mitochondrial tRNA-isoleucine (MTTI; {590045}).
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Familial hypertrophic cardiomyopathy 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Familial hypertrophic cardiomyopathy 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Familial hypertrophic cardiomyopathy 1" returned 0 free, full-text research articles on human participants.

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Familial hypertrophic cardiomyopathy 1" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Congenital Muscle Disease Study of Patient and Family Reported Medical Information
 

Status: Recruiting

Condition Summary: Muscular Dystrophy; Congenital Muscular Dystrophy; Fukutin-related Protein Gene; Limb Girdle; FKRP Gene; Childhood Onset LGMD; Adult Onset LGMD; POMT1; POMT2; POMGnT1; LARGE; Alpha Dystroglycan; Dystroglycanopathy; Centronuclear; Multiminicore; Multicore; Minicore; Congenital Fiber Type Disproportion; Myotubular; Nemaline; Congenital Myopathy; Neuromuscular; Rigid Spine; Phenotype-Genotype Correlation; Cough Assisted Device; Neuromuscular Disease; Respiratory Exacerbation; Invasive Ventilation; Chest Physiotherapy; Congenital Myopathies; Genetic Mutations; Hypertrophic Cardiomyopathy; Wheelchair Use; Cataract; Opthalmoplegia; Ullrich Congenital Muscular Dystrophy; Intermediate Collagen VI Myopathy; Laminin Alpha 2 Related Congenital Muscular Dystrophy; MDC1A; Merosin Deficient Congenital Muscular Dystrophy; Congenital Muscular Dystrophy Undiagnosed; Congenital Muscular Dystrophy Merosin Positive; Walker Warburg Syndrome; Muscle Eye Brain Disease; Fukuyama; Integrin Alpha 7 Deficiency; Integrin Alpha 9 Deficiency; Laminopathy; Lamin AC; SEPN 1 Related Myopathies; Bethlem Myopathy; Dystroglycanopathies; LGMD2K; LGMD2I; LGMD2L; LGMD2N; Actin Aggregation Myopathy; Cap Disease; Central Core Disease; Centronuclear Myopathy; Core Rod Myopathy; Hyaline Body Myopathy; Multiminicore Myopathy; Myotubular Myopathy; Nemaline Myopathy; Tubular Aggregate Myopathy; Zebra Body Disease Myopathy; Congenital Myopathy Other; Reducing Body Myopathy; Sarcotubular Myopathy; Spheroid Body Myopathy

 

Last Updated: 13 Nov 2013

Go to URL